Monoclonal antibodies specific for anthrax spores and peptides derived from the antibodies thereof

a technology of anthrax spores and monoclonal antibodies, which is applied in the field of monoclonal antibodies specific for anthrax spores and peptides derived from the antibodies thereof, can solve the problems of lack of accuracy and limited sensitivity, complex methods, and high cost of systems, and achieves low cost and high sensitivity. the effect of reducing the risk of infection

Inactive Publication Date: 2007-01-25
KEARNEY JOHN
View PDF6 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, these methods are complex, expensive, cumbersome, and slow, typically requiring spore germination and outgrowth of vegetative cells.
These systems are relatively fast because they detect spores directly.
However, current antibody-based detectors suffer from a lack of accuracy and limited sensitivity, which result in an unacceptably high level of both false-positive and false-negative responses, according to federal government trials (www.gsa / gov / mailpolicy) and other independent tests [D. King, et al., J. Clin. Microbiol. 41:3454-3455 (2003)].
The lack of accuracy with these systems is compounded by the normal presence in the environment of Bacillus spores that resemble (and share surface antigens with) B. anthracis spores.
Particularly problematic are spores of the opportunistic human pathogen B. cereus and the insect pathogen B. thuringiensis, species which, based on genome sequence comparisons, are the most similar to B. anthracis [Read et al., Nature, 423:81-86 (2003
1993)]. Therefore, due to the aforementioned limitations and deficiencies, all currently available systems for detecting B. anthracis are inadequate for frontline use by emergency workers and soldiers on the battlefield and for routine monitoring of publ
However, none of the above references suggest using phage display peptide libraries for identifying peptide sequences which bind to whole cells, such as bacteria spores.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Monoclonal antibodies specific for anthrax spores and peptides derived from the antibodies thereof
  • Monoclonal antibodies specific for anthrax spores and peptides derived from the antibodies thereof
  • Monoclonal antibodies specific for anthrax spores and peptides derived from the antibodies thereof

Examples

Experimental program
Comparison scheme
Effect test

example 1

General Method of Biopanning of Phage Display Peptide Libraries with Bacillus Spores

[0036] Peptides of interest were identified using a phage display ligand screening system. A phage display peptide library kit (New England Bio Labs) was used according to instructions of the manufacturer in the identification process. These libraries display random 7- and 12-mer peptides, respectively, on the surface of the filamentous coliphage M13. These peptides are fused to the surface-exposed amino terminus of the minor capsid protein pIII, which is present in five copies at one end of the phage particle. Thus, each phage displays five copies of one particular peptide. The phage display peptide libraries, each contain approximately 2×109 independent phage clones. Each clone produces a protein pIII-peptide fusion that was created by the insertion of a random 21- or 36-base DNA fragment into a cloning site at the start of gene III of the phage. Consequently, the sequence of any peptide that bind...

example 2

Identification of B. subtilis-Specific Peptides

(a) Determination of the 7-mer Peptides

[0038] The DNA of over thirty independent phage isolates of B. subtilis were sequenced and thirteen unique sequences were identified. (See Table 1.) All encoded peptides contained amino terminal sequence Asn-His-Phe-Leu (SEQ ID No. 118). Although the sequences at positions five through seven are not identical, there is a clear preference for certain amino acids.

TABLE 1Nucleotide and Amino Acid Sequences fromB. subtilis Spore-Binding PhageIsolate 1AAT CAT TTT TTG ATT AAG CCG (SEQ ID No.2) 2AAT CAT TTT TTG AGG TCT CCG (SEQ ID No.3) 3AAT CAT TTT CTG CCT CGT TGG (SEQ ID No.4) 4AAT CAT TTT CTT CCT AAG GTG (SEQ ID No.5) 5AAT CAT TTT CTG TTG CCG CCG (SEQ ID No.6) 6AAT CAT TTT TTG CCT CCT CGG (SEQ ID No.7) 7AAT CAT TTT CTG CCT ACT GGG (SEQ ID No.8) 8AAT CAT TTT CTG ATG CCG AAG (SEQ ID No.9) 9AAT CAT TTT CTT AAG GGG ACG (SEQ ID No.10)10AAT CAT TTT TTG CCG CAG AAT (SEQ ID No.11)11AAT CAT TTT CTT CTT TGG...

example 3

Identification of B. anthracis-Specific Peptides

(a) Biopanning of B. anthracis-Specific Peptides with Avirulent ΔAmes Strain of B. anthracis

[0051] Biopanning with the heptamer phage display library was used to identify tight-binding peptides on the surface of B. anthracis spores. The spores were prepared from the avirulent delta-Ames strain of the organism (lacking the toxin-encoding plasmid pOX1) and were sterilized by gamma-irradiation by Diagnostics Systems Division of the U.S. Army Medical Research Institute of Infectious Disease, Fort Detrick, Md.

[0052] Four rounds of biopanning were performed in the manner described above. The genomic DNA of amplified elutes from each round were sequenced directly and genomic DNA of 27 single plaques from the fourth round amplified elute were also sequenced. In the fourth round of biopanning, the defining decrease in titer of the supernatant and the increase in the titer of the elutate indicated the selection of tight-binding phages. The D...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
pHaaaaaaaaaa
pHaaaaaaaaaa
wave lengthsaaaaaaaaaa
Login to view more

Abstract

The present invention relates to peptides that bind to the bacterial spores, such as B. anthracis, B. subtilis and B. cereus spores. The present invention also relates to method of identifying such peptides using phage display ligand screening system. The present invention further relates to the use of such peptides for the detection of bacterial spores, such as Bacillus anthracis spores.

Description

[0001] This application is a continuation-in-part of U.S. patent application Ser. No. 09 / 229,751, filed Jan. 14, 1999, which claims priority from U.S. Provisional Application Ser. No. 60 / 071,411, filed Jan. 14, 1998. The entirety of these applications are incorporated herein by reference.FIELD OF THE INVENTION [0002] The present invention relates to means of identifying and capturing spore-forming bacteria comprising preparation of peptides which bind to the surfaces of bacterial spores. The peptides are identified using a phage display ligand screening system. BACKGROUND OF THE INVENTION [0003] The capture and identification of bacterial spores is useful for detecting pathogenic or otherwise harmful bacteria. Often the presence of spores can indicate to the researcher or epidemiologist the presence of virulent organisms. It is also important to determine the presence of spores of pathogenic organisms in the environment in order to more effectively control spread of infections. The ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K39/40G01N33/554C07K16/12
CPCC07K16/1278G01N2333/32G01N33/56911C07K2317/565
Inventor KEARNEY, JOHN
Owner KEARNEY JOHN
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products